Target intelligence / Profile preview

Human neutrophil elastase and pancreatic elastase (HNE and PE)

Target
HNE and PE
Molecular classification
Enzyme, Serine protease, Hydrolase
01

Overview

Human neutrophil elastase (HNE) and pancreatic elastase (PE) are serine proteases that play pivotal roles in tissue homeostasis and the inflammatory response [2, 12]. HNE, encoded by the ELANE gene, is primarily found in the azurophilic granules of neutrophils and is released to degrade extracellular matrix proteins such as elastin and collagen, while also contributing to the destruction of engulfed pathogens [12, 13]. Pancreatic elastases, including members of the chymotrypsin-like elastase (CELA) family, are traditionally known for their role in protein digestion in the gut, but specific isoforms like CELA1 are also expressed in the lung where they contribute to strain-mediated matrix remodeling [6, 15]. An imbalance between these proteolytic enzymes and their endogenous inhibitors, most notably alpha-1 antitrypsin, is a central driver of tissue destruction in chronic obstructive pulmonary disease (COPD), emphysema, and acute respiratory distress syndrome (ARDS) [13, 19]. Therapeutic interventions include the use of selective inhibitors like sivelestat for acute lung injury and alvelestat for alpha-1 antitrypsin deficiency, as well as augmentation therapy with purified alpha-1 antitrypsin to restore the protease-antiprotease balance [1, 19, 21].

Other names
PMN elastaseLeukocyte elastaseELANECELA1CELA2ACELA3ACELA3BMedullasinElastase-2
02

Mechanism of action

Competitive inhibition of the serine protease active site, preventing the degradation of elastin and other extracellular matrix proteins [1, 12].

03

Biological functions

Proteolysis [2]Immune response [12]Extracellular matrix degradation [12]Digestion [11]Bactericidal activity [12]
04

Disease associations

Chronic obstructive pulmonary disease (COPD) [13]Acute respiratory distress syndrome (ARDS) [1, 13]Alpha-1 antitrypsin deficiency [19]Cystic fibrosis [13]Pancreatitis [18]Emphysema [6, 15]Acute lung injury (ALI) [1, 20]
05

Safety considerations

Impaired host defense against bacterial infections [12]Potential off-target protease inhibition [13, 14]Headache and gastrointestinal issues associated with synthetic inhibitors [19, 21]
06

Interacting drugs

Sivelestat [1, 12]

6 more in the full profile.

07

Biomarkers

Fecal elastase-1 [2, 11]Desmosine [19]Isodesmosine [19]Aα-Val360 [19, 21]

Beyond the preview

Go deeper on Human neutrophil elastase and pancreatic elastase (HNE and PE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human neutrophil elastase and pancreatic elastase (HNE and PE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call